These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1058211)

  • 1. Effect of human lysozyme (muramidase) on potassium handling by the perfused rat kidney. A mechanism for renal damage in human monocytic leukaemia.
    Mason DY; Howes DT; Taylor CR; Ross BD
    J Clin Pathol; 1975 Sep; 28(9):722-7. PubMed ID: 1058211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muramidasuria and hyperkaluria in the chloroleukemic rat.
    Rosenthal DS; Maglio R; Moloney WC
    Proc Soc Exp Biol Med; 1972 Nov; 141(2):499-500. PubMed ID: 4508508
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship of lysozyme to the nephropathy in chloroleukemic rats and the effects of lysozyme loading on normal rat kidneys.
    Klockars M; Azar HA; Hermida R; Isobe T; Hsu CC; Ansari H; Osserman EF
    Cancer Res; 1974 Jan; 34(1):47-60. PubMed ID: 4588549
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum and urinary proteins, lysozyme (muramidase), and renal dysfunction in mono- and myelomonocytic leukemia.
    Pruzanski W; Platts ME
    J Clin Invest; 1970 Sep; 49(9):1694-708. PubMed ID: 5270914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal handling of endogenous lysozyme in man.
    Pruzanski W; Wilson DR
    J Lab Clin Med; 1977 Jul; 90(1):61-7. PubMed ID: 267155
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal handling of endogenous lysozyme in the rat.
    Cojocel C; Baumann K
    Ren Physiol; 1983; 6(6):258-65. PubMed ID: 6648026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal handling of low molecular weight proteins.
    Maack T
    Am J Med; 1975 Jan; 58(1):57-64. PubMed ID: 1090151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysozymuria and renal tubular dysfunction in monocytic and myelomonocytic leukemia.
    Muggia FM; Heinemann HO; Farhangi M; Osserman EF
    Am J Med; 1969 Sep; 47(3):351-66. PubMed ID: 5258033
    [No Abstract]   [Full Text] [Related]  

  • 9. Monocytic and monomyelocytic leukaemia with increased serum and urine lysozyme as a late complication in plasma cell myeloma.
    Osserman EF
    Br Med J; 1971 May; 2(5757):327. PubMed ID: 5280477
    [No Abstract]   [Full Text] [Related]  

  • 10. [Leukocyte lysozymes in various forms of leukemia].
    Jaworkowsky L; Grant H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(1):11-23. PubMed ID: 69568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.
    Osserman EF; Lawlor DP
    J Exp Med; 1966 Nov; 124(5):921-52. PubMed ID: 5224561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysozyme: a brief review.
    Mir MA
    Postgrad Med J; 1977 May; 53(619):257-9. PubMed ID: 267280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudohyperkalemia due to release of potassium from white blood cells during clotting.
    Bronson WR; DeVita VT; Carbone PP; Cotlove E
    N Engl J Med; 1966 Feb; 274(7):369-75. PubMed ID: 5216594
    [No Abstract]   [Full Text] [Related]  

  • 14. Early nephrotoxicity at high plasma concentrations of lysozyme in the rat.
    Cojocel C; Dociu N; Baumann K
    Lab Invest; 1982 Feb; 46(2):149-57. PubMed ID: 7062720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of lysozyme estimations in acute myeloid and chronic monocytic leukaemia.
    Catovsky D; Galton DA; Griffin C
    Br J Haematol; 1971 Nov; 21(5):565-80. PubMed ID: 5286441
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-1 producing ability of leukaemia cells and its relationship to morphological diagnosis.
    Furukawa Y; Ohta M; Miura Y; Saito M
    Br J Haematol; 1987 Jan; 65(1):11-5. PubMed ID: 3493026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight proteins as carriers for renal drug targeting: naproxen-lysozyme.
    Franssen EJ; van Amsterdam RG; Visser J; Moolenaar F; de Zeeuw D; Meijer DK
    Pharm Res; 1991 Oct; 8(10):1223-30. PubMed ID: 1796038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary lysozyme phenotypes in monocytic leukemia.
    Virella G; Goudswaard J; Tischendorf FW; Fudenberg HH
    Clin Chim Acta; 1977 Sep; 79(2):503-6. PubMed ID: 268245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the renal tubular reabsorption of rat beta-2-microglobulin by lysozyme in perfused rat.
    Viau C; Wouters JR; Chouinard S
    Contrib Nephrol; 1990; 83():88-92. PubMed ID: 2100725
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lysozyme-induced nephropathy: A rare cause of renal failure in chronic myelomonocytic leukemia].
    Robinet-Zimmermann G; Rioux-Leclercq N; Frouget T; Le Naoures C
    Ann Pathol; 2020 Nov; 40(6):478-482. PubMed ID: 32444242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.